Efficacy and safety of dronedarone after recent cardioversion in patients with atrial fibrillation/flutter: a post-hoc analysis of the EURIDIS/ADONIS trials

Back

ESC Premium Access

Efficacy and safety of dronedarone after recent cardioversion in patients with atrial fibrillation/flutter: a post-hoc analysis of the EURIDIS/ADONIS trials

Session: Poster Session 2 - Drug treatment for atrial fibrillation

Topic: Treatment

Speaker: Professor H. Crijns (Maastricht, NL)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Professor Harry Crijns

Maastricht University Medical Centre (MUMC), Maastricht (Netherlands (The))

24 presentations

0 follower

9 more presentations in this session

Prevalence and risk of DOACs inappropriate dosing in atrial fibrillation. An analysis of the Swiss-AF and BEAT-AF registries

Speaker: Doctor G. Montrasio (London, GB)

Access

Abstract

Slides

Heparin and low-molecular-weight heparin switch associated with an increase in bleeding complications in patients on apixaban undergoing catheter ablation: The AMPER ABLATION study

Speaker: Doctor W. Amara (Le Raincy-Montfermeil, FR)

Access

Abstract

Amiodarone treatment duration and reasons for permanent drug discontinuation in patients with atrial fibrillation

Speaker: Doctor M. Mihajlovic (Belgrade, RS)

Access

Abstract

Slides

Use of direct thrombin inhibitor on the day of atrial fibrillation ablation decreases incidence of silent cerebral ischemia detected by magnetic resonance imaging

Speaker: Associate Professor M. Harada (Toyoake, JP)

Access

Abstract

Comparison of efficacy of different anticoagulation strategies used during pulmonary vein isolation in left atrial blood samples

Speaker: Doctor O. Hajas (Debrecen, HU)

Access

Abstract

Slides

Access the full session

Poster Session 2 - Drug treatment for atrial fibrillation

Speakers: Professor H. Crijns, Doctor G. Montrasio, Doctor W. Amara, Doctor M. Mihajlovic, Associate Professor M. Harada...

Access

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources